Molecular mechanism and potential targets for blocking HPV-induced lesion development

Journal of Oncology

Volumn , Issue , 2012, Pages

  Guzman Olea E ^a,b   Bermudez Morales V H ^a   Peralta Zaragoza, O ^a   Torres Poveda, K ^a   Madrid Marina, V ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b Universidad Politecnica del Estado de Morelos   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MITOMYCIN; MITOXANTRONE; OXALIPLATIN; PACLITAXEL; TOPOTECAN; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DNA REPAIR; DNA REPLICATION; GENE EXPRESSION; GENE SILENCING; GRANULOCYTE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; INNATE IMMUNITY; LOW DRUG DOSE; MACROPHAGE; MOLECULARLY TARGETED THERAPY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; REVIEW; RNA INTERFERENCE; TUMOR ESCAPE; TUMOR MICROENVIRONMENT; TUMOR REGRESSION; UTERINE CERVIX CANCER;

EID: 84855608187     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/278312     Document Type: Review

References (97)

1. Mougin C., Dalstein V., Prétet J. L., Gay C., Schaal J. P., Riethmuller D., Epidemiology of HPV cervical infections: recent knowledge Presse Medicale 2001 30 20 1017 1023 (Pubitemid 32547593)
2. Mougin C., Mo L., Dalstein V., Natural history of papillomavirus infections Revue du Praticien 2006 56 17 1883 1889 (Pubitemid 44875355)
3. Sheu B. C., Chang W. C., Lin H. H., Chow S. N., Huang S. C., Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia Journal of Obstetrics and Gynaecology Research 2007 33 2 103 113
4. Old L. J., Tumor immunology: the first century Current Opinion in Immunology 1992 4 5 603 607
5. Giannini S. L., Al-Saleh W., Piron H., Jacobs N., Doyen J., Boniver J., Delvenne P., Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression Clinical and Experimental Immunology 1998 113 2 183 189 (Pubitemid 28352835)
6. Alcocer-Gonzlez J. M., Berumen J., Taméz-Guerra R., Bermdez-Morales V., Peralta-Zaragoza O., Hernndez-Pando R., Moreno J., Gariglio P., Madrid-Marina V., In vivo expression of immunosuppressive cytokines in human papillomavirus-transfonned cervical cancer cells Viral Immunology 2006 19 3 481 491 (Pubitemid 44735060)
7. Daz-Bentez C. E., Navarro-Fuentes K. R., Flores-Sosa J. A., Jurez-Daz J., Uribe-Salas F. J., Romn-Basaure E., Gonzlez-Mena L. E., Alonso De Ruz P., Lpez-Estrada G., Lagunas-Martnez A., Bermdez-Morales V. H., Alcocer-Gonzlez J. M., Martnez-Barnetche J., Hernndez-Pando R., Rosenstein Y., Moreno J., Madrid-Marina V., CD3 expression and T cell proliferation are inhibited by TGF- 1 and IL-10 in cervical cancer patients Journal of Clinical Immunology 2009 29 4 532 544
8. De Gruijl T. D., Bontkes H. J., Peccatori F., Gallee M. P. W., Helmerhorst T. J. M., Verheijen R. H. M., Aarbiou J., Mulder W. M. C., Walboomers J. M. M., Meijer C. J. L. M., Van De Vange N., Scheper R. J., Expression of CD3- on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes British Journal of Cancer 1999 79 7-8 1127 1132 (Pubitemid 29087885)
9. Santin A. D., Ravaggi A., Bellone S., Pecorelli S., Cannon M., Parham G. P., Hermonat P. L., Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix Gynecologic Oncology 2001 81 3 424 432 (Pubitemid 32494657)
10. Sheu B. C., Lin R. H., Lien H. C., Ho H. N., Hsu S. M., Huang S. C., Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer Journal of Immunology 2001 167 5 2972 2978
11. Bermudez-Morales V. H., Gutiérrez L. X., Alcocer-Gonzlez J. M., Burguete A., Madrid-Marina V., Correlation between IL-10 gene expression and HPV infection in cervical cancer: a mechanism for immune response escape Cancer Investigation 2008 26 10 1037 1043
12. Bais A. G., Beckmann I., Lindemans J., Ewing P. C., Meijer C. J. L. M., Snijders P. J. F., Helmerhorst T. J. M., A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions Journal of Clinical Pathology 2005 58 10 1096 1100 (Pubitemid 41416062)
13. De Gruijl T. D., Bontkes H. J., Van den Muysenberg A. J. C., Van Oostveen J. W., Stukart M. J., Verheijen R. H. M., Van der Vange N., Snijders P. J. F., Meijer C. J. L. M., Walboomers J. M. M., Scheper R. J., Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix European Journal of Cancer 1999 35 3 490 497 (Pubitemid 29157871)
14. Fiorentino D. F., Zlotnik A., Mosmann T. R., Howard M., O'Garra A., IL-10 inhibits cytokine production by activated macrophages Journal of Immunology 1991 147 11 3815 3822
15. Shondel S. M., Helm C. W., Gercel-Taylor C., Taylor D. D., Differential expression of T-cell CD3-zeta chains in patients with cervical dysplasia before and after treatment International Journal of Gynecological Cancer 2007 17 6 1278 1282 (Pubitemid 350077347)
16. Lepique A. P., Daghastanli K. R. P., Cuccovia I., Villa L. L., HPV16 tumor associated macrophages suppress antitumor T cell responses Clinical Cancer Research 2009 15 13 4391 4400
17. Bolpetti A., Silva J. S., Villa L. L., Lepique A. P., Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth BMC Immunology 2010 11, article 27
18. Gabrilovich D. I., Velders M. P., Sotomayor E. M., Kast W. M., Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells Journal of Immunology 2001 166 9 5398 5406 (Pubitemid 32374159)
19. Trottier H., Franco E. L., Human papillomavirus and cervical cancer: burden of illness and basis for prevention American Journal of Managed Care 2006 12 17 S462 S472
20. Stanley M., Immune responses to human papillomavirus Vaccine 2006 24 1 S16 S22
21. Peralta-Zaragoza O., Bermdez-Morales V., Gutiérrez-Xicotencatl L., Alcocer-Gonzlez J., Recillas-Targa F., Madrid-Marina V., E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor 1 promoter throughout Sp1 recognition sequence Viral Immunology 2006 19 3 468 480 (Pubitemid 44735059)
22. Bermdez-Morales V. H., Peralta-Zaragoza O., Alcocer-Gonzlez J. M., Moreno J., Madrid-Marina V., IL-10 expression is regulated by HPV E2 protein in cervical cancer cells Molecular Medicine Reports 2011 4 2 369 375
23. Ahmad M., Rees R. C., Ali S. A., Escape from immunotherapy: possible mechanisms that influence tumor regression/progression Cancer Immunology, Immunotherapy 2004 53 10 844 854 (Pubitemid 39312652)
24. Lai M. C., Teh B. H., Tarn W. Y., A human papillomavirus E2 transcriptional activator: the interactions with cellular splicing factors and potential function in pre-mRNA processing The Journal of Biological Chemistry 1999 274 17 11832 11841
25. Baker C. C., Phelps W. C., Lindgren V., Braun M. J., Gonda M. A., Howley P. M., Structural and transcriptional analysis of human papilloma- virus type 16 sequences in cervical carcinoma cell lines Journal of Virology 1987 19 962 971 (Pubitemid 17044004)
26. Thierry F., Yaniv M., The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region The EMBO Journal 1987 6 11 3391 3397
27. Hwang E. S., Naegerm L. K., DiMario D., Acti- vation of the endogenous p53 growth in- hibitory pathway in HeLa cervical carci- noma cells by expression of the bovine papillomavirus E2 gene Oncogene 1996 12 795 803
28. Hwang E. S., Riese D. J., Settleman J., Nilson L. A., Honig J., Flynn S., DiMaio D., Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene Journal of Virology 1993 67 7 3720 3729 (Pubitemid 23180692)
29. Desaintes C., Demeret C., Goyat S., Yaniv M., Thierry F., Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis The EMBO Journal 1997 16 3 504 514 (Pubitemid 27067780)
30. Dowhanick J. J., McBride A. A., Howley P. M., Suppression of cellular proliferation by the papillomavirus E2 protein Journal of Virology 1995 69 12 7791 7799
31. Demeret C., Garcia-Carranca A., Thierry F., Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein Oncogene 2003 22 2 168 175 (Pubitemid 36174174)
32. Blachon S., Demeret C., The regulatory E2 proteins of human genital papillomaviruses are pro-apoptotic Biochimie 2003 85 8 813 819 (Pubitemid 37383800)
33. Desaintes C., Goyat S., Garbay S., Yaniv M., Thierry F., Papillomavirus E2 induces p53-independent apoptosis in HeLa cells Oncogene 1999 18 32 4538 4545 (Pubitemid 29405885)
34. Webster K., Parish J., Pandya M., Stern P. L., Clarke A. R., Gaston K., The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway The Journal of Biological Chemistry 2000 275 1 87 94 (Pubitemid 30038957)
35. Rosales C., Valadez Graham V., Rosas G. A., Merchant H., Rosales R., A recombinant vaccinia virus containing the papilloma E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity Cancer Immunology Immunotherapy 2000 49 7 347 360
36. Graham V. V., Sutter G., José M. V., Garca-Carranca A., Erfle V., Mendoza N. M., Merchant H., Rosales R., Human tumor growth is inhibited by a vaccinia virus carrying the E2 gene of bovine papillomavirus Cancer 2000 88 7 1650 1662 (Pubitemid 30183151)
37. Berumen J., Casas L., Segura E., Amezcua J. L., Garcia-Carranca A., Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes International Journal of Cancer 1994 56 5 640 645 (Pubitemid 24086764)
38. Bermdez-Morales V. H., Peralta-Zaragoza O., Guzmn-Olea E., Garca-Carranc A., Bahena-Romn M., Alcocer-Gonzlez J. M., Madrid-Marina V., HPV 16 E2 protein induces apoptosis in human and murine HPV 16 transformed epithelial cells and has antitumoral effects in vivo Tumor Biology 2009 30 2 61 72
39. Dranoff G., Cytokines in cancer pathogenesis and cancer therapy Nature Reviews Cancer 2004 4 1 11 22 (Pubitemid 38111131)
40. Clerici M., Merola M., Ferrario E., Trabattoni D., Villa M. L., Stefanon B., Venzon D. J., Shearer G. M., De Palo G., Clerici E., Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection Journal of the National Cancer Institute 1997 89 3 245 250 (Pubitemid 27073762)
41. Bermdez-Morales V. H., Peralta-Zaragoza O., Madrid-Marina V., Gene therapy with cytokines against cervical cancer Salud Publica de Mexico 2005 47 6 458 468 (Pubitemid 43187097)
42. Del Vecchio M., Bajetta E., Canova S., Lotze M. T., Wesa A., Parmiani G., Anichini A., Interleukin-12: biological properties and clinical application Clinical Cancer Research 2007 13 16 4677 4685 (Pubitemid 47294773)
43. Yin X., Yan X., Yang Q., Cao H., Liang H., AntiTumor mechanism of recombinant murine interleukin-12 vaccine Cancer Biotherapy and Radiopharmaceuticals 2010 25 3 263 268
44. Steding C. E., Wu S.-T., Zhang Y., Jeng M.-H., Elzey B. D., Kao C., The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis Immunology 2011 133 2 221 238
45. Marchi L. H. L., Paschoalin T., Travassos L. R., Rodrigues E. G., Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon- -dependent response against B16F10-Nex2 melanoma Cancer Gene Therapy 2010 18 2 110 122
46. Komita H., Zhao X., Katakam A. K., Kumar P., Kawabe M., Okada H., Braughler J. M., Storkus W. J., Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity Cancer Gene Therapy 2009 16 12 883 891
47. Ahn W. S., Bae S. M., Kim T. Y., Kim T. G., Lee J. M., Namkoong S. E., Kim C. K., Sin J. I., A therapy modality using recombinant IL-12 adenovirus plus E7 protein in a human papillomavirus 16 E6/E7-associated cervical cancer animal model Human Gene Therapy 2003 14 15 1389 1399 (Pubitemid 37268218)
48. He Y. K., Lui V. W. Y., Baar J., Wang L., Shurin M., Almonte C., Watkins S. C., Huang L., Potentiation of E7 antisense RNA-induced antitumor immunity by co-delivery of IL-12 gene in HPV16 DNA-positive mouse tumor Gene Therapy 1998 5 11 1462 1471 (Pubitemid 28517373)
49. Hallez S., Detremmerie O., Giannouli C., Thielemans K., Gajewski T. F., Burny A., Oberdan L., Interleukin-12-secreting human papillomavirus type 16-transformed cells provide a potent cancer vaccine that generates E7-directed immunity International Journal of Cancer 1999 81 3 428 437 (Pubitemid 29165202)
50. Taga K., Mostowski H., Tosato G., Human interleukin-10 can directly inhibit T-cell growth Blood 1993 81 11 2964 2971 (Pubitemid 23162114)
51. Indrov M., Bubenk J., Mikyskov R., Mendoza L., Smov J., Bieblov J., Jandlov T., Jinoch P., Smahel M., Vonka V., Pajtasz-Piasecka E., Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines International Journal of Oncology 2003 22 3 691 695
52. De vita F., Orditura M., Galizia G., Serum interleukin-10 is an independent prognos-tic factor in advanced solid tumors Oncology Reports 2000 7 357 361
53. Mocellin S., Marincola F. M., Young H. A., Interleukin-10 and the immune response against cancer: a counterpoint Journal of Leukocyte Biology 2005 78 5 1043 1051 (Pubitemid 41572467)
54. Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M., Moore K. W., O'Garra A., IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells Journal of Immunology 1991 146 10 3444 3451
55. De Waal Malefyt R., Haanen J., Spits H., Roncarolo M. G., Te Velde A., Figdor C., Johnson K., Kastelein R., Yssel H., De Vries J. E., Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression Journal of Experimental Medicine 1991 174 4 915 924
56. MacNeil I. A., Suda T., Moore K. W., Mosmann T. R., Zlotnik A., IL-10, a novel growth cofactor for mature and immature T cells Journal of Immunology 1990 145 12 4167 4173
57. Chen W. F., Zlotnik A., IL-10: a novel cytotoxic T cell differentiation factor Journal of Immunology 1991 147 2 528 534
58. Go N. F., Castle B. E., Barrett R., Kastelein R., Dang W., Mosmann T. R., Moore K. W., Howard M., Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells Journal of Experimental Medicine 1990 172 6 1625 1631
59. Kim J., Modlin R. L., Moy R. L., Dubinett S. M., McHugh T., Nickoloff B. J., Uyemura K., IL-10 production in cutaneous basal and squamous cell carcinomas: a mechanism for evading the local T cell immune response Journal of Immunology 1995 155 4 2240 2247
60. Yue F. Y., Dummer R., Geertsen R., Hofbauer G., Laine E., Manolio S., Burg G., Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules International Journal of Cancer 1997 71 4 630 637 (Pubitemid 27239375)
61. Garca-Hernndez M. L., Hernndez-Pando R., Gariglio P., Berumen J., Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation Immunology 2002 105 2 231 243 (Pubitemid 34146690)
62. Matar P., Rozados V. R., Gervasoni S. I., Scharovsky O. G., Down regulation of T-cell-derived IL-10 production by low-dose cyclophosphamide treatment in tumor-bearing rats restores in vitro normal lymphoproliferative response International Immunopharmacology 2001 1 2 307 319 (Pubitemid 32183729)
63. Jovasevic V. M., Gorelik L., Bluestone J. A., Mokyr M. B., Importance of IL-10 for CTLA-4-Mediated Inhibition of Tumor-Eradicating Immunity Journal of Immunology 2004 172 3 1449 1454 (Pubitemid 38116787)
64. Vicari A. P., Chiodoni C., Vaure C., At-Yahia S., Dercamp C., Matsos F., Reynard O., Taverne C., Merle P., Colombo M. P., O'Garra A., Trinchieri G., Caux C., Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody Journal of Experimental Medicine 2002 196 4 541 549
65. Kim B. G., Joo H. G., Chung I. S., Chung H. Y., Woo H. J., Yun Y. S., Inhibition of interleukin-10 (IL-10) production from MOPC 315 tumor cells by IL-10 antisense oligodeoxynucleotides enhances cell-mediated immune responses Cancer Immunology Immunotherapy 2000 49 8 433 440
66. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T., Identification of novel genes coding for small expressed RNAs Science 2001 294 5543 853 858 (Pubitemid 33032103)
67. Lau N. C., Lim L. P., Weinstein E. G., Bartel D. P., An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans Science 2001 294 5543 858 862 (Pubitemid 33032104)
68. Lee R. C., Ambros V., An extensive class of small RNAs in Caenorhabditis elegans Science 2001 294 5543 862 864 (Pubitemid 33032105)
69. Doench J. G., Petersen C. P., Sharp P. A., siRNAs can function as miRNAs Genes and Development 2003 17 4 438 442 (Pubitemid 36258757)
70. Elbashir S. M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T., Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 2001 411 6836 494 498 (Pubitemid 32494397)
71. Elbashir S. M., Martinez J., Patkaniowska A., Lendeckel W., Tuschl T., Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate The EMBO Journal 2001 20 23 6877 6888 (Pubitemid 33134217)
72. Jiang M., Milner J., Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference Oncogene 2002 21 39 6041 6048
73. Yoshinouchi M., Yamada T., Kizaki M., Fen J., Koseki T., Ikeda Y., Nishihara T., Yamato K., In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA Molecular Therapy 2003 8 5 762 768 (Pubitemid 37527451)
74. Butz K., Ristriani T., Hengstermann A., Denk C., Scheffner M., Hoppe-Seyler F., siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells Oncogene 2003 22 38 5938 5945 (Pubitemid 37175872)
75. Lea J. S., Sunaga N., Sato M., Kalahasti G., Miller D. S., Minna J. D., Muller C. Y., Silencing of HPV 18 oncoproteins with RNA interference causes growth inhibition of cervical cancer cells Reproductive Sciences 2007 14 1 20 28 (Pubitemid 351168772)
76. Butz K., Denk C., Ullmann A., Scheffner M., Hoppe-Seyler F., Induction of apoptosis in human papillomavirus-positive cancer cells by peptide aptamers targeting the viral E6 oncoprotein Proceedings of the National Academy of Sciences of the United States of America 2000 97 12 6693 6697 (Pubitemid 30412776)
77. Scheffner M., Werness B. A., Huibregtse J. M., Levine A. J., Howley P. M., The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 1990 63 6 1129 1136 (Pubitemid 120035062)
78. Thomas M., Banks L., Inhibition of Bak-induced apoptosis by HPV-18 E6 Oncogene 1998 17 23 2943 2954 (Pubitemid 29012197)
79. Filippova M., Parkhurst L., Duerksen-Hughes P. J., The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis The Journal of Biological Chemistry 2004 279 24 25729 25744 (Pubitemid 38756837)
80. Garnett T. O., Filippova M., Duerksen-Hughes P. J., Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis Cell Death and Differentiation 2006 13 11 1915 1926 (Pubitemid 44542404)
81. Gross-Mesilaty S., Reinstein E., Bercovich B., Tobias K. E., Schwartz A. L., Kahana C., Ciechanover A., Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway Proceedings of the National Academy of Sciences of the United States of America 1998 95 14 8058 8063 (Pubitemid 28326065)
82. Lagunas-Martnez A., Madrid-Marina V., Gariglio P., Modulation of apoptosis by early human papillomavirus proteins in cervical cancer Biochimica et Biophysica Acta 2010 1805 1 6 16
83. Filippova M., Song H., Connolly J. L., Dermody T. S., Duerksen-Hughes P. J., The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis The Journal of Biological Chemistry 2002 277 24 21730 21739 (Pubitemid 34952324)
84. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X., Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors Cell 1998 94 4 481 490 (Pubitemid 28391864)
85. Kuwano H., Sumiyoshi K., Sonoda K., Kitamura K., Toh Y., Nakashima H., Sugimachi K., Pathogenesis of esophageal squamous cell carcinoma with lymphoid stroma Hepato-Gastroenterology 2001 48 38 458 461 (Pubitemid 32391590)
86. Putral L. N., Bywater M. J., Gu W., Saunders N. A., Gabrielli B. G., Leggatt G. R., McMillan N. A. J., RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin Molecular Pharmacology 2005 68 5 1311 1319 (Pubitemid 41539987)
87. Niu X. Y., Peng Z. L., Duan W. Q., Wang H., Wang P., Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo International Journal of Gynecological Cancer 2006 16 2 743 751
88. Jiang M., Rubbi C. P., Milner J., Gel-based application of siRNA to human epithelial cancer cells induces RNAi-dependent apoptosis Oligonucleotides 2004 14 4 239 248 (Pubitemid 40144362)
89. Takuma F., Miyuki S., Eri I., Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer International Journal of Oncology 2006 29 3 541 548
90. Gu W., Putral L., McMillan N., SiRNA and shRNA as anticancer agents in a cervical cancer model Methods in Molecular Biology 2008 442 159 172
91. Kuner R., Vogt M., Sultmann H., Buness A., Dymalla S., Bulkescher J., Fellmann M., Butz K., Poustka A., Hoppe-Seyler F., Identification of cellular targets for the human papillomavirus E6 and E7 oncogenes by RNA interference and transcriptome analyses Journal of Molecular Medicine 2007 85 11 1253 1262 (Pubitemid 47622224)
92. Peter M., Rosty C., Couturier J., Radvanyi F., Teshima H., Sastre-Garau X., MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors Oncogene 2006 25 44 5985 5993 (Pubitemid 44477292)
93. DeFilippis R. A., Goodwin E. C., Wu L., DiMaio D., Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells Journal of Virology 2003 77 2 1551 1563 (Pubitemid 36055574)
94. Koivusalo R., Krausz E., Helenius H., Hietanen S., Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs Molecular Pharmacology 2005 68 2 372 382 (Pubitemid 41058301)
95. Yamato K., Yamada T., Kizaki M., New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer Cancer Gene Therapy 2008 15 140 153 (Pubitemid 351240669)
96. Sima N., Wang W., Kong D., RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53 Apoptosi 2008 13 273 281
97. Salazar-Len J., Reyes-Romn F., Meneses-Acosta A., Silencing of HPV16 E6 and E7 oncogenic activities by small interference RNA induces autophagy and apoptosis in human cervical cancer cells Journal of Nucleic Acids Investigation 2011 2 59 69